<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[NeuroVive Pharmaceutical AB 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=13292></link><description><![CDATA[NeuroVive Pharmaceutical AB 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Mon, 07 Sep 2026 06:22:16 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[NeuroVive Successfully Completes Clinical Trial with Cremophor-free Cyclosporine I.V. Formulation]]></title><link>https://www.newswire.co.kr/newsRead.php?no=465629</link><description><![CDATA[룬드 스웨덴--(뉴스와이어)--NeuroVive Pharmaceutical AB (Aktietorget:NVP) reports that its Phase I clinical study comparing the Cremophor(R)-free intravenous cyclosporine formula NeuroSTAT(R) to Sandimmune(R) Injection met primary and secondary endpoints. Results of the study demonstrate that NeuroSTAT(R) is bioequivalent to Sandimmune(R) Injection and is safe and well tol...]]></description><pubDate>Fri, 02 Apr 2010 10:12:05 +0900</pubDate></item></channel></rss>